课题基金 / 基金详情

Differential Neuro-Biological Correlates of Emotion- and Stress-Processing in Generalized Anxiety Disorder compared to Major Depression and Social Phobia

Differential Neuro-Biological Correlates of Emotion- and Stress-Processing in Generalized Anxiety Disorder compared to Major Depression and Social Phobia
与重度抑郁症和社交恐惧症相比,广泛性焦虑症的情绪和压力处理的差异神经生物学相关性
批准号:
245227249
负责人:
Professorin Dr. Katja Beesdo-Baum
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2013
资助国家:
德国
项目状态:
已结题
起止时间:
2012-12-31 至 2017-12-31

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
广泛性焦虑症(GAD)是一种以过度、无法控制的焦虑和焦虑预期为特征的慢性临床疾病。GAD的病因发病机制尚不清楚。神经生物学的发现尤其稀少且前后不一致。功能神经成像研究指出,与健康对照组相比,广泛性阿尔茨海默病患者的杏仁核和相关的恐惧电路网络的神经结构被夸大地激活。然而,类似的激活模式在神经成像研究中也被报道,这些疾病经常与GAD并存,如抑郁症或其他焦虑症。因此,GAD的神经影像结果的特异性仍不清楚。少数关于GAD应激系统功能障碍的研究表明,交感神经反应性升高和下丘脑-垂体-肾上腺轴(HPAA)过度激活,导致皮质醇释放,但也有部分内分泌应激反应降低的报道。这些不同应激系统解离的迹象可能是GAD中HPAA重新编程的结果。然而,之前的结果在多大程度上再次受到频繁的合并症的影响仍不清楚。这项基础研究和准实验性对比病例对照研究旨在研究广泛性AD患者情绪和应激加工的神经、内分泌和自主神经的相关性,并明确重度抑郁症(MD)和社交恐惧症(SP)的共同和不同特征。通过功能磁共振成像(FMRI)对初发GAD(无共病抑郁或SP)、原发MD(无共患焦虑症)、原发SP(无共病抑郁或GAD)受试者和无精神疾病的健康对照组进行检查,以揭示神经关联,同时完成一个具有注意状态变化的面孔-情绪范式、一个不同的恐惧条件范式以及一个在感知过程中情绪刺激的预期和模糊性变化的范式。此外,与情绪处理和调节相关的大脑区域之间的功能连接正在通过静息状态分析的方式进行评估。基础(头发皮质醇)和急性应激参数(唾液皮质醇、α-淀粉酶、皮肤电导率)在心理应激情况下被评估。研究结果有望有助于更好地描述和理解GAD中的神经生物学相关因素及其相互作用,并有助于与MD和SP区分开来,为诊断、分类和治疗提供参考。
英文摘要
Generalized Anxiety Disorder (GAD) is a chronic clinical condition characterized by excessive, uncontrollable worry and anxious expectations. The aetio-pathogenesis of GAD remains poorly understood. Neuro-biological findings are particularly scarce and inconsistent. Functional neuroimaging studies point to exaggerated activation in the amygdala and associated neural structures of the fear circuitry network in subjects with GAD compared to healthy controls. However, similar activation patterns are reported in neuroimaging studies on disorders that frequently co-occur with GAD, such as Depression or other anxiety disorders. Therefore, the specificity of the neuroimaging results for GAD remains unclear. The few available studies on possible dysfunctions of the stress system in GAD suggest an elevated sympathetic reactivity and hyperactivation of the hypothalamic-pituitary-adrenal axis (HPAA), which leads to the release of cortisol, but partly a reduced endocrine stress reactivity has been reported as well. These indications for a dissociation of different stress systems may possibly be a result of a reprogrammed HPAA in GAD. However, it remains unclear in how far previous results are again mediated by frequent comorbidities. This basic research and quasi-experimental comparative case-control-study aims to investigate the neural, endocrine and autonomic correlates of emotion and stress processing in subjects with GAD and to specify common and distinct features with regard to major depression (MD) on the one hand and Social Phobia (SP) on the other hand. Subjects with primary GAD (no comorbid depression or SP), primary MD (no comorbid anxiety disorder), primary SP (no comorbid depression or GAD) and healthy controls without psychopathology are examined via functional magnetic resonance imaging (fMRI) to reveal neural correlates while completing a face-emotion paradigm with variation of attention state, a differential fear conditioning paradigm, and a paradigm varying certainty during anticipation and ambiguity of emotional stimuli during perception. Additionally, functional connectivity between brain areas related to emotional processing and regulation is being assessed by means of a resting-state analysis. Basal (hair cortisol) and acute stress parameters (saliva cortisol, alpha amylase, skin conductance) are assessed in psychological stress situations. Results are expected to contribute to an improved characterization and understanding of the neuro-biologic correlates and their interplay in GAD and to allow differentiation from MD and SP with implications for diagnosis, classification and treatment.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Characterisation of three major functional networks using graph-analysis across internalising disorders
使用跨内化障碍的图形分析表征三个主要功能网络
DOI: 10.1016/j.euroneuro.2018.11.739
发表时间: 2019
期刊: European Neuropsychopharmacology
影响因子: 5.6
作者: [Hilbert, K. Lueken, Beesdo-Baum]
通讯作者: Beesdo-Baum
海外基金